Avastin challenges Lucentis dominance in wet AMD

Avastin challenges Lucentis dominance in wet AMD

Posted on 26th April 2012

The leading wet AMD treatment used in the NHS, Lucentis, is under pressure from a cheaper version called Avastin.

Both compounds are from the family of AntiVEGF drugs (anti-vascular endothelial growth factor). In wet AMD, the degeneration causes the retina to make tiny new blood vessels in response to damage. These blood vessels are very fragile and break and bleed into the retina causing scarring and eventually vision loss.

AntiVEGF drugs stop and even shrink the growth of these new blood vessels preventing the damaging bleeding. Until now Lucentis has been the only approved drug for use in the eye and costs over £700 per injection (used in multiples of 3 injections normally). Avastin is in the same family of drugs and currently used to treat heart conditions. Costing only £60 per injection, many specialists in other countries have been using it ‘off label’ in the eye to great effect.

Avastin is now being used to treat 50% of AMD cases in the US and there is increasing pressure on the NHS to approve the use of this drug enabling far more access to the sight saving treatment.

At Cameron Optometry, we’re experts in all forms of macular disease and have the latest OCT technology which is used by specialists to diagnose and monitor the effects of treatment on wet AMD. If you are concerned or have a family history of the condition, come and see us for some expert advice.


Related Posts

Cameron Optometry shortlisted for Independent Practice of the Year Award

20th February 2017

We are delighted to announce that we have been shortlisted for UK Independent Practice of the Year at the Optician Awards 2017. The judges have debated, scrutinised and voted on every entry and we ...

Read more

Scientists develop new way to diagnose cataracts

24th January 2017

There is really encouraging news coming out of Edinburgh’s very own Heriot Watt University today. Scientists there have developed a new way to diagnose cataracts, which on the face of it may not see...

Read more

Why Michael McIntyre has got it all wrong about eye examinations!

16th January 2017

It’s officially ‘Blue Monday’, so for all our blog followers we thought a little humour was required. I recently watched this sketch from Michael McIntyre about visiting the optician. If you nee...

Read more

Let your eyewear give you a new look in 2017

10th January 2017

Have you started the year desperately seeking a new look? We may well have the answer. In the last few months we have welcomed some stylish, independent eyewear brands to the practice. So if you want ...

Read more